Subjects: MICRORNAS, DIABETES MELLITUS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEIXOTO, Renata D'Alpino et al. Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]. Pancreas. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/MPA.0000000000002040. Acesso em: 04 nov. 2024. , 2022APA
Peixoto, R. D. 'A., Donnarumma, C. D. C., Matheus, L. H. G., Santos, A. S., Santos-Bezerra, D. P., Matos, M. R. de, et al. (2022). Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta]. Pancreas. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. doi:10.1097/MPA.0000000000002040NLM
Peixoto RD'A, Donnarumma CDC, Matheus LHG, Santos AS, Santos-Bezerra DP, Matos MR de, Neves JAJ, Camacho CP, Giannella MLCC. Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta] [Internet]. Pancreas. 2022 ; 51( 5): E76-E77.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1097/MPA.0000000000002040Vancouver
Peixoto RD'A, Donnarumma CDC, Matheus LHG, Santos AS, Santos-Bezerra DP, Matos MR de, Neves JAJ, Camacho CP, Giannella MLCC. Validation of serum MicroRNAs-19a,-24, and-29a as potential markers to differentiate pancreatic cancer-associated diabetes From type 2 diabetes mellitus. [Carta] [Internet]. Pancreas. 2022 ; 51( 5): E76-E77.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1097/MPA.0000000000002040